OMIDRIA
Commercial- Indications
- Cataract surgery
Company intelligence / Profile preview
Rayner
Worthing, West Sussex, United Kingdomrayner.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Rayner is a leading British medical device company specializing in the design and manufacture of intraocular lenses (IOLs), proprietary injection devices for cataract surgery, and ophthalmic solutions such as OMIDRIA. The company pioneered IOL technology with Sir Harold Ridley since the first successful lens implantation in the late 1940s. Its products are distributed globally and are approved by major regulatory agencies including the FDA. The company's portfolio includes a range of IOLs—monofocal, toric, multifocal—and combination drugs to support ocular health. It remains privately held with ongoing innovation in ophthalmology.
- Therapeutic areas
- Ophthalmology
- Modalities
- DeviceSmall molecule
- Industry
- Implantable Medical Devices
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Rayner.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rayner.